Genotypes and cephalosporin susceptibility in extended-spectrum beta-lactamase producing enterobacteriaceae in the community

Journal of Infection in Developing Countries

Volumn 6, Issue 6, 2012, Pages 470-477

  Maina, Daniel ^a   Revathi, Gunturu ^a   Kariuki, Samuel ^b   Ozwara, Hastings ^c  

^a AGA KHAN UNIVERSITY   (Kenya)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c INSTITUTE OF PRIMATE RESEARCH   (Kenya)

Author keywords

ESBL producing escherichia coli and klebsiella pneumoniae; Genotype; MIC

Indexed keywords

BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CLAVULANIC ACID; HYDROLASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CHILD; COMMUNICABLE DISEASE; DISK DIFFUSION; DRUG SENSITIVITY; EPSILOMETER TEST; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; URINALYSIS;

EID: 84862678740     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.1456     Document Type: Article

References (23)

1. Rodríguez-Baño J, Navarro MD, Romero L (2004) Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients. J Clin Microbiol 42: 1089-1094.
2. Paterson DL (2000) Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs). Clin Microbiol Infect 6: 460-463.
3. Paterson DL and Yu VL (1999) Extended-spectrum beta-lactamases: a call for improved detection and control. Clin Infect Dis 29: 1419-1422.
4. Medeiros AA (1997) Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics. Clin Infect Dis 24: S19-45.
5. Kariuki S, Corkill JE, Revathi G, Musoke R, Hart CA (2001) Molecular characterization of a novel plasmid-encoded cefotaximase (CTXM-12) found in clinical Klebsiella pneumoniae isolates from Kenya. Antimicrob Agents Chemother 45: 2141-2143.
6. Kariuki S, Revathi G, Corkill J, Kiiru J, Mwituria J, Mirza N, Hart CA (2007) Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams. J Infect Dev Ctries 1: 257-262.
7. Brooks JT, Ochieng JB, Kumar L, Okoth G, Shapiro RL, Wells JG, Bird M, Bopp C, Chege W, Beatty ME, Chiller T, Vulule JM, Mintz E, Slutsker L (2006) Surveillance for bacterial diarrhea and antimicrobial resistance in rural western Kenya, 1997-2003. Clin Infect Dis 43: 393-401.
8. Clinical Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibility testing; 19th informational supplement.CLSI/NCCLS M100-S19. Wayne, Pennsylvania.
9. Philippon A, Arlet G, Jacoby GA (2002) Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 46: 1-11.
10. Edelstein M, Pimkin M, Palagin I, Edelstein I, Stratchounski L (2003) Prevalence and molecular epidemiology of CTX-M extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Russian hospitals. Antimicrob Agents Chemother 47: 3724-3732.
11. Lal P, Kapil A, Das BK, Sood S (2007) Occurrence of TEM & SHV gene in extended spectrum beta-lactamases (ESBLs) producing Klebsiella sp. isolated from a tertiary care hospital. Indian J Med Res 125: 173-178.
12. Nuesch-Inderbinen MT, Hachler H, Kayser FH (1996) Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. Eur J Clin Microbiol Infect Dis 15: 398-402.
13. Canton R and Coque TM (2006) The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 9: 466-475.
14. Tian GB, Garcia J, Adams-Haduch JM, Evangelista JP, Destura RV, Wang N and Doi Y (2010) CTX-M as the predominant extended-spectrum beta-lactamases among Enterobacteriaceae in Manila, Philippines. J Antimicrob Chemother 65: 584-586.
15. Morris D, Boyle F, Buckley V, Xu L, Hanahoe B, Hawkey P, Cormican M (2009) CTX-M enzymes are the predominant extended-spectrum beta-lactamases produced by Enterobacteriaceae in Ireland. J Antimicrob Chemother 64: 864-866.
16. Song W and Lee H (2009) CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum b-lactamase in clinical isolates of Escherichia coli from Korea. Journal of Medical Microbiology 58: 261-266.
17. Pitout JD, Nordmann P, Laupland KB, Poirel L (2005) Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 56: 52-59.
18. Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tortola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Pena C, Llanos AC, Canton R, Pascual A (2008) Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 168: 1897-1902.
19. Bonnet R (2004) Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob Agents Chemother 48, 1-14.
20. Paterson DL and RA Bonomo (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18: 657-686.
21. Bin C, Hui W, Renyuan Z (2006) Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum β-lactamase-producing Escherichia coli. Diagn Microbiol Infect Dis 56: 351-357.
22. Tribuddharat C, Srifuengfung S and Chiangjong W (2007) A Correlation between Phenotypes and Genotypes of Extended-Spectrum Beta-Lactamase (ESBL)-Producing Klebsiella pneumoniae in a University Hospital, Thailand. J Infect Dis Antimicrob Agents 24: 117-123.
23. Pitout JD and Laupland KB (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: 159-166.